Category: Disease States

Disease States

Circulogene Launches Tissue-Based Genomic Profiling Assay for Solid Tumors

OncoGenDx analyzes 335 DNA genes and 72 RNA genes using next-generation sequencing technology to support treatment decisions.

Disease States

Pancreatic Cancer Study Reaches 10,000 Participants Worldwide

The PRECEDE Consortium doubles its enrollment target to 20,000 as it builds a dataset for early detection tool development.

Disease States

AI-Driven Platform Aims to Bring Personalized Cancer Treatment to More Patients

First Ascent Biomedical is validating a live-cell testing platform that screens over 150 FDA-approved therapies against a patient’s tumor, generating individualized treatment insights in about 10 days.

Cancer

Quest Diagnostics to Expand Blood-Based Colorectal Cancer Screening Access

The company is collaborating with Guardant Health to make Guardant's Shield test available through Quest's nationwide network of provider clients and patient service centers.

Infectious Diseases

Mayo Clinic Launches Focused Nine-Gene Panel for Hereditary Pancreatitis

The new test expands from four genes to nine while maintaining clinical focus, addressing diagnostic challenges with PRSS1 testing accuracy.

Womens Health

Fellow Health Joins Progyny Network for Home Male Fertility Testing

Partnership provides mail-in semen analysis as a covered benefit for eligible members.

Allergy & Autoimmune

Why Laboratory Insights Are Critical During Asthma Peak Week

From rising demand for comprehensive IgE profiles to the emergence of molecular allergen diagnostics, laboratories are central to how clinicians prepare for and manage September’s asthma spike.

Cardiovascular, Cerebrovascular

Should Labs Add Lp(a) Testing to Their Menus?

Lipoprotein(a), or Lp(a), is a genetically determined and under-recognized cardiovascular disease risk factor.

Dementias & Alzheimer’s

C2N Diagnostics Lowers Age Limit for Alzheimer’s Blood Test to 50

C2N Diagnostics has expanded the intended use of its PrecivityAD2 Alzheimer's disease blood test to include patients 50 years and older, lowering the previous age limit from 60 years.

Diabetes & Metabolic Diseases

Balancing POC and Lab Testing for Diabetes Management

It's essential to integrate point-of-care testing devices cautiously alongside traditional laboratory tests to ensure robust diabetes management.

Kidney Disease

Carna Health, Siemens Healthineers Partner on AI-Enabled CKD Platform

The agreement aims to improve early detection and management of chronic kidney disease in underserved populations through integrated diagnostics and digital health solutions.

Respiratory Disease

Yourgene Health Cystic Fibrosis Assay Receives IVDR Accreditation

The Cystic Fibrosis Base assay has received IVDR accreditation, ensuring high standards for detecting cystic fibrosis mutations.

Sepsis

DOD Awards $4.87M for Handheld Sepsis Diagnostic Device

Washington University researchers are developing a rapid test to classify sepsis patients into inflammatory profiles for targeted treatment.